nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Discomfort—Dactinomycin—germ cell cancer	0.00274	0.00274	CcSEcCtD
Gadoversetamide—Anorexia—Bleomycin—germ cell cancer	0.00272	0.00272	CcSEcCtD
Gadoversetamide—Thrombophlebitis—Methotrexate—germ cell cancer	0.00271	0.00271	CcSEcCtD
Gadoversetamide—Hypoaesthesia—Etoposide—germ cell cancer	0.0027	0.0027	CcSEcCtD
Gadoversetamide—Malaise—Ifosfamide—germ cell cancer	0.00269	0.00269	CcSEcCtD
Gadoversetamide—Vertigo—Ifosfamide—germ cell cancer	0.00268	0.00268	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Etoposide—germ cell cancer	0.00268	0.00268	CcSEcCtD
Gadoversetamide—Immune system disorder—Cisplatin—germ cell cancer	0.00267	0.00267	CcSEcCtD
Gadoversetamide—Abdominal pain—Vinblastine—germ cell cancer	0.00267	0.00267	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Cisplatin—germ cell cancer	0.00267	0.00267	CcSEcCtD
Gadoversetamide—Hypotension—Bleomycin—germ cell cancer	0.00267	0.00267	CcSEcCtD
Gadoversetamide—Oedema—Dactinomycin—germ cell cancer	0.00266	0.00266	CcSEcCtD
Gadoversetamide—Urethral disorder—Etoposide—germ cell cancer	0.00266	0.00266	CcSEcCtD
Gadoversetamide—Arrhythmia—Cisplatin—germ cell cancer	0.00264	0.00264	CcSEcCtD
Gadoversetamide—Palpitations—Ifosfamide—germ cell cancer	0.00264	0.00264	CcSEcCtD
Gadoversetamide—Cough—Ifosfamide—germ cell cancer	0.00261	0.00261	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00261	0.00261	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.0026	0.0026	CcSEcCtD
Gadoversetamide—Convulsion—Ifosfamide—germ cell cancer	0.00259	0.00259	CcSEcCtD
Gadoversetamide—Hypertension—Ifosfamide—germ cell cancer	0.00258	0.00258	CcSEcCtD
Gadoversetamide—Malnutrition—Cisplatin—germ cell cancer	0.00258	0.00258	CcSEcCtD
Gadoversetamide—Erythema—Cisplatin—germ cell cancer	0.00258	0.00258	CcSEcCtD
Gadoversetamide—Erythema multiforme—Etoposide—germ cell cancer	0.00256	0.00256	CcSEcCtD
Gadoversetamide—Paraesthesia—Bleomycin—germ cell cancer	0.00256	0.00256	CcSEcCtD
Gadoversetamide—Dyspnoea—Bleomycin—germ cell cancer	0.00254	0.00254	CcSEcCtD
Gadoversetamide—Chest pain—Ifosfamide—germ cell cancer	0.00254	0.00254	CcSEcCtD
Gadoversetamide—Arthralgia—Ifosfamide—germ cell cancer	0.00254	0.00254	CcSEcCtD
Gadoversetamide—Myalgia—Ifosfamide—germ cell cancer	0.00254	0.00254	CcSEcCtD
Gadoversetamide—Flatulence—Cisplatin—germ cell cancer	0.00254	0.00254	CcSEcCtD
Gadoversetamide—Anorexia—Dactinomycin—germ cell cancer	0.00254	0.00254	CcSEcCtD
Gadoversetamide—Eye disorder—Etoposide—germ cell cancer	0.00253	0.00253	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00253	0.00253	CcSEcCtD
Gadoversetamide—Flushing—Etoposide—germ cell cancer	0.00252	0.00252	CcSEcCtD
Gadoversetamide—Cardiac disorder—Etoposide—germ cell cancer	0.00252	0.00252	CcSEcCtD
Gadoversetamide—Discomfort—Ifosfamide—germ cell cancer	0.00251	0.00251	CcSEcCtD
Gadoversetamide—Hypersensitivity—Vinblastine—germ cell cancer	0.00249	0.00249	CcSEcCtD
Gadoversetamide—Decreased appetite—Bleomycin—germ cell cancer	0.00248	0.00248	CcSEcCtD
Gadoversetamide—Muscle spasms—Cisplatin—germ cell cancer	0.00248	0.00248	CcSEcCtD
Gadoversetamide—Angiopathy—Etoposide—germ cell cancer	0.00246	0.00246	CcSEcCtD
Gadoversetamide—Confusional state—Ifosfamide—germ cell cancer	0.00246	0.00246	CcSEcCtD
Gadoversetamide—Immune system disorder—Etoposide—germ cell cancer	0.00245	0.00245	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Etoposide—germ cell cancer	0.00244	0.00244	CcSEcCtD
Gadoversetamide—Pain—Bleomycin—germ cell cancer	0.00244	0.00244	CcSEcCtD
Gadoversetamide—Oedema—Ifosfamide—germ cell cancer	0.00244	0.00244	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00244	0.00244	CcSEcCtD
Gadoversetamide—Chills—Etoposide—germ cell cancer	0.00243	0.00243	CcSEcCtD
Gadoversetamide—Vision blurred—Cisplatin—germ cell cancer	0.00243	0.00243	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00242	0.00242	CcSEcCtD
Gadoversetamide—Asthenia—Vinblastine—germ cell cancer	0.00242	0.00242	CcSEcCtD
Gadoversetamide—Tremor—Cisplatin—germ cell cancer	0.00241	0.00241	CcSEcCtD
Gadoversetamide—Nervous system disorder—Ifosfamide—germ cell cancer	0.00239	0.00239	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Cisplatin—germ cell cancer	0.00239	0.00239	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00239	0.00239	CcSEcCtD
Gadoversetamide—Skin disorder—Ifosfamide—germ cell cancer	0.00237	0.00237	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00236	0.00236	CcSEcCtD
Gadoversetamide—Feeling abnormal—Bleomycin—germ cell cancer	0.00235	0.00235	CcSEcCtD
Gadoversetamide—Anorexia—Ifosfamide—germ cell cancer	0.00232	0.00232	CcSEcCtD
Gadoversetamide—Malaise—Cisplatin—germ cell cancer	0.00232	0.00232	CcSEcCtD
Gadoversetamide—Decreased appetite—Dactinomycin—germ cell cancer	0.00231	0.00231	CcSEcCtD
Gadoversetamide—Diarrhoea—Vinblastine—germ cell cancer	0.00231	0.00231	CcSEcCtD
Gadoversetamide—Dysgeusia—Etoposide—germ cell cancer	0.00231	0.00231	CcSEcCtD
Gadoversetamide—Fatigue—Dactinomycin—germ cell cancer	0.00229	0.00229	CcSEcCtD
Gadoversetamide—Back pain—Etoposide—germ cell cancer	0.00228	0.00228	CcSEcCtD
Gadoversetamide—Hypotension—Ifosfamide—germ cell cancer	0.00228	0.00228	CcSEcCtD
Gadoversetamide—Pain—Dactinomycin—germ cell cancer	0.00228	0.00228	CcSEcCtD
Gadoversetamide—Muscle spasms—Etoposide—germ cell cancer	0.00227	0.00227	CcSEcCtD
Gadoversetamide—Urticaria—Bleomycin—germ cell cancer	0.00227	0.00227	CcSEcCtD
Gadoversetamide—Body temperature increased—Bleomycin—germ cell cancer	0.00226	0.00226	CcSEcCtD
Gadoversetamide—Dizziness—Vinblastine—germ cell cancer	0.00223	0.00223	CcSEcCtD
Gadoversetamide—Convulsion—Cisplatin—germ cell cancer	0.00223	0.00223	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00222	0.00222	CcSEcCtD
Gadoversetamide—Myalgia—Cisplatin—germ cell cancer	0.00219	0.00219	CcSEcCtD
Gadoversetamide—Feeling abnormal—Dactinomycin—germ cell cancer	0.00219	0.00219	CcSEcCtD
Gadoversetamide—Paraesthesia—Ifosfamide—germ cell cancer	0.00219	0.00219	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Etoposide—germ cell cancer	0.00219	0.00219	CcSEcCtD
Gadoversetamide—Anxiety—Cisplatin—germ cell cancer	0.00219	0.00219	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00218	0.00218	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00218	0.00218	CcSEcCtD
Gadoversetamide—Dyspnoea—Ifosfamide—germ cell cancer	0.00217	0.00217	CcSEcCtD
Gadoversetamide—Somnolence—Ifosfamide—germ cell cancer	0.00217	0.00217	CcSEcCtD
Gadoversetamide—Discomfort—Cisplatin—germ cell cancer	0.00217	0.00217	CcSEcCtD
Gadoversetamide—Vomiting—Vinblastine—germ cell cancer	0.00215	0.00215	CcSEcCtD
Gadoversetamide—Malaise—Etoposide—germ cell cancer	0.00213	0.00213	CcSEcCtD
Gadoversetamide—Vertigo—Etoposide—germ cell cancer	0.00212	0.00212	CcSEcCtD
Gadoversetamide—Decreased appetite—Ifosfamide—germ cell cancer	0.00212	0.00212	CcSEcCtD
Gadoversetamide—Headache—Vinblastine—germ cell cancer	0.00212	0.00212	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00211	0.00211	CcSEcCtD
Gadoversetamide—Abdominal pain—Dactinomycin—germ cell cancer	0.0021	0.0021	CcSEcCtD
Gadoversetamide—Body temperature increased—Dactinomycin—germ cell cancer	0.0021	0.0021	CcSEcCtD
Gadoversetamide—Fatigue—Ifosfamide—germ cell cancer	0.0021	0.0021	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Cisplatin—germ cell cancer	0.0021	0.0021	CcSEcCtD
Gadoversetamide—Oedema—Cisplatin—germ cell cancer	0.0021	0.0021	CcSEcCtD
Gadoversetamide—Hypersensitivity—Bleomycin—germ cell cancer	0.0021	0.0021	CcSEcCtD
Gadoversetamide—Pain—Ifosfamide—germ cell cancer	0.00209	0.00209	CcSEcCtD
Gadoversetamide—Constipation—Ifosfamide—germ cell cancer	0.00209	0.00209	CcSEcCtD
Gadoversetamide—Loss of consciousness—Etoposide—germ cell cancer	0.00207	0.00207	CcSEcCtD
Gadoversetamide—Nervous system disorder—Cisplatin—germ cell cancer	0.00206	0.00206	CcSEcCtD
Gadoversetamide—Cough—Etoposide—germ cell cancer	0.00206	0.00206	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Cisplatin—germ cell cancer	0.00206	0.00206	CcSEcCtD
Gadoversetamide—Tachycardia—Cisplatin—germ cell cancer	0.00205	0.00205	CcSEcCtD
Gadoversetamide—Asthenia—Bleomycin—germ cell cancer	0.00205	0.00205	CcSEcCtD
Gadoversetamide—Convulsion—Etoposide—germ cell cancer	0.00204	0.00204	CcSEcCtD
Gadoversetamide—Skin disorder—Cisplatin—germ cell cancer	0.00204	0.00204	CcSEcCtD
Gadoversetamide—Hypertension—Etoposide—germ cell cancer	0.00204	0.00204	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Cisplatin—germ cell cancer	0.00203	0.00203	CcSEcCtD
Gadoversetamide—Asthma—Methotrexate—germ cell cancer	0.00203	0.00203	CcSEcCtD
Gadoversetamide—Pruritus—Bleomycin—germ cell cancer	0.00202	0.00202	CcSEcCtD
Gadoversetamide—Feeling abnormal—Ifosfamide—germ cell cancer	0.00201	0.00201	CcSEcCtD
Gadoversetamide—Chest pain—Etoposide—germ cell cancer	0.00201	0.00201	CcSEcCtD
Gadoversetamide—Nausea—Vinblastine—germ cell cancer	0.00201	0.00201	CcSEcCtD
Gadoversetamide—Anorexia—Cisplatin—germ cell cancer	0.002	0.002	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.002	0.002	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00199	0.00199	CcSEcCtD
Gadoversetamide—Discomfort—Etoposide—germ cell cancer	0.00199	0.00199	CcSEcCtD
Gadoversetamide—Hypotension—Cisplatin—germ cell cancer	0.00196	0.00196	CcSEcCtD
Gadoversetamide—Hypersensitivity—Dactinomycin—germ cell cancer	0.00196	0.00196	CcSEcCtD
Gadoversetamide—Confusional state—Etoposide—germ cell cancer	0.00194	0.00194	CcSEcCtD
Gadoversetamide—Urticaria—Ifosfamide—germ cell cancer	0.00194	0.00194	CcSEcCtD
Gadoversetamide—Abdominal pain—Ifosfamide—germ cell cancer	0.00193	0.00193	CcSEcCtD
Gadoversetamide—Body temperature increased—Ifosfamide—germ cell cancer	0.00193	0.00193	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Etoposide—germ cell cancer	0.00193	0.00193	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00192	0.00192	CcSEcCtD
Gadoversetamide—Asthenia—Dactinomycin—germ cell cancer	0.00191	0.00191	CcSEcCtD
Gadoversetamide—Dysuria—Methotrexate—germ cell cancer	0.0019	0.0019	CcSEcCtD
Gadoversetamide—Paraesthesia—Cisplatin—germ cell cancer	0.00189	0.00189	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Etoposide—germ cell cancer	0.00189	0.00189	CcSEcCtD
Gadoversetamide—Tachycardia—Etoposide—germ cell cancer	0.00188	0.00188	CcSEcCtD
Gadoversetamide—Dyspnoea—Cisplatin—germ cell cancer	0.00187	0.00187	CcSEcCtD
Gadoversetamide—Skin disorder—Etoposide—germ cell cancer	0.00187	0.00187	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Etoposide—germ cell cancer	0.00186	0.00186	CcSEcCtD
Gadoversetamide—Anorexia—Etoposide—germ cell cancer	0.00184	0.00184	CcSEcCtD
Gadoversetamide—Decreased appetite—Cisplatin—germ cell cancer	0.00183	0.00183	CcSEcCtD
Gadoversetamide—Diarrhoea—Dactinomycin—germ cell cancer	0.00182	0.00182	CcSEcCtD
Gadoversetamide—Pneumonia—Methotrexate—germ cell cancer	0.00182	0.00182	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00182	0.00182	CcSEcCtD
Gadoversetamide—Vomiting—Bleomycin—germ cell cancer	0.00181	0.00181	CcSEcCtD
Gadoversetamide—Hypotension—Etoposide—germ cell cancer	0.0018	0.0018	CcSEcCtD
Gadoversetamide—Rash—Bleomycin—germ cell cancer	0.0018	0.0018	CcSEcCtD
Gadoversetamide—Pain—Cisplatin—germ cell cancer	0.0018	0.0018	CcSEcCtD
Gadoversetamide—Dermatitis—Bleomycin—germ cell cancer	0.0018	0.0018	CcSEcCtD
Gadoversetamide—Hypersensitivity—Ifosfamide—germ cell cancer	0.0018	0.0018	CcSEcCtD
Gadoversetamide—Conjunctivitis—Methotrexate—germ cell cancer	0.00176	0.00176	CcSEcCtD
Gadoversetamide—Asthenia—Ifosfamide—germ cell cancer	0.00175	0.00175	CcSEcCtD
Gadoversetamide—Feeling abnormal—Cisplatin—germ cell cancer	0.00173	0.00173	CcSEcCtD
Gadoversetamide—Paraesthesia—Etoposide—germ cell cancer	0.00173	0.00173	CcSEcCtD
Gadoversetamide—Pruritus—Ifosfamide—germ cell cancer	0.00173	0.00173	CcSEcCtD
Gadoversetamide—Haematuria—Methotrexate—germ cell cancer	0.00172	0.00172	CcSEcCtD
Gadoversetamide—Dyspnoea—Etoposide—germ cell cancer	0.00172	0.00172	CcSEcCtD
Gadoversetamide—Somnolence—Etoposide—germ cell cancer	0.00171	0.00171	CcSEcCtD
Gadoversetamide—Epistaxis—Methotrexate—germ cell cancer	0.00171	0.00171	CcSEcCtD
Gadoversetamide—Nausea—Bleomycin—germ cell cancer	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Vomiting—Dactinomycin—germ cell cancer	0.00169	0.00169	CcSEcCtD
Gadoversetamide—Rash—Dactinomycin—germ cell cancer	0.00168	0.00168	CcSEcCtD
Gadoversetamide—Decreased appetite—Etoposide—germ cell cancer	0.00167	0.00167	CcSEcCtD
Gadoversetamide—Diarrhoea—Ifosfamide—germ cell cancer	0.00167	0.00167	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00166	0.00166	CcSEcCtD
Gadoversetamide—Body temperature increased—Cisplatin—germ cell cancer	0.00166	0.00166	CcSEcCtD
Gadoversetamide—Fatigue—Etoposide—germ cell cancer	0.00166	0.00166	CcSEcCtD
Gadoversetamide—Pain—Etoposide—germ cell cancer	0.00165	0.00165	CcSEcCtD
Gadoversetamide—Constipation—Etoposide—germ cell cancer	0.00165	0.00165	CcSEcCtD
Gadoversetamide—Haemoglobin—Methotrexate—germ cell cancer	0.00163	0.00163	CcSEcCtD
Gadoversetamide—Haemorrhage—Methotrexate—germ cell cancer	0.00162	0.00162	CcSEcCtD
Gadoversetamide—Dizziness—Ifosfamide—germ cell cancer	0.00161	0.00161	CcSEcCtD
Gadoversetamide—Pharyngitis—Methotrexate—germ cell cancer	0.00161	0.00161	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Methotrexate—germ cell cancer	0.0016	0.0016	CcSEcCtD
Gadoversetamide—Urethral disorder—Methotrexate—germ cell cancer	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Feeling abnormal—Etoposide—germ cell cancer	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Nausea—Dactinomycin—germ cell cancer	0.00158	0.00158	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Etoposide—germ cell cancer	0.00158	0.00158	CcSEcCtD
Gadoversetamide—Vomiting—Ifosfamide—germ cell cancer	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Hypersensitivity—Cisplatin—germ cell cancer	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Rash—Ifosfamide—germ cell cancer	0.00154	0.00154	CcSEcCtD
Gadoversetamide—Dermatitis—Ifosfamide—germ cell cancer	0.00154	0.00154	CcSEcCtD
Gadoversetamide—Erythema multiforme—Methotrexate—germ cell cancer	0.00154	0.00154	CcSEcCtD
Gadoversetamide—Urticaria—Etoposide—germ cell cancer	0.00153	0.00153	CcSEcCtD
Gadoversetamide—Abdominal pain—Etoposide—germ cell cancer	0.00152	0.00152	CcSEcCtD
Gadoversetamide—Body temperature increased—Etoposide—germ cell cancer	0.00152	0.00152	CcSEcCtD
Gadoversetamide—Eye disorder—Methotrexate—germ cell cancer	0.00152	0.00152	CcSEcCtD
Gadoversetamide—Tinnitus—Methotrexate—germ cell cancer	0.00151	0.00151	CcSEcCtD
Gadoversetamide—Asthenia—Cisplatin—germ cell cancer	0.00151	0.00151	CcSEcCtD
Gadoversetamide—Cardiac disorder—Methotrexate—germ cell cancer	0.00151	0.00151	CcSEcCtD
Gadoversetamide—Angiopathy—Methotrexate—germ cell cancer	0.00147	0.00147	CcSEcCtD
Gadoversetamide—Immune system disorder—Methotrexate—germ cell cancer	0.00147	0.00147	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Methotrexate—germ cell cancer	0.00146	0.00146	CcSEcCtD
Gadoversetamide—Chills—Methotrexate—germ cell cancer	0.00146	0.00146	CcSEcCtD
Gadoversetamide—Nausea—Ifosfamide—germ cell cancer	0.00145	0.00145	CcSEcCtD
Gadoversetamide—Diarrhoea—Cisplatin—germ cell cancer	0.00144	0.00144	CcSEcCtD
Gadoversetamide—Mental disorder—Methotrexate—germ cell cancer	0.00142	0.00142	CcSEcCtD
Gadoversetamide—Hypersensitivity—Etoposide—germ cell cancer	0.00142	0.00142	CcSEcCtD
Gadoversetamide—Malnutrition—Methotrexate—germ cell cancer	0.00141	0.00141	CcSEcCtD
Gadoversetamide—Erythema—Methotrexate—germ cell cancer	0.00141	0.00141	CcSEcCtD
Gadoversetamide—Dysgeusia—Methotrexate—germ cell cancer	0.00138	0.00138	CcSEcCtD
Gadoversetamide—Asthenia—Etoposide—germ cell cancer	0.00138	0.00138	CcSEcCtD
Gadoversetamide—Back pain—Methotrexate—germ cell cancer	0.00137	0.00137	CcSEcCtD
Gadoversetamide—Pruritus—Etoposide—germ cell cancer	0.00136	0.00136	CcSEcCtD
Gadoversetamide—Vomiting—Cisplatin—germ cell cancer	0.00134	0.00134	CcSEcCtD
Gadoversetamide—Vision blurred—Methotrexate—germ cell cancer	0.00133	0.00133	CcSEcCtD
Gadoversetamide—Rash—Cisplatin—germ cell cancer	0.00133	0.00133	CcSEcCtD
Gadoversetamide—Dermatitis—Cisplatin—germ cell cancer	0.00132	0.00132	CcSEcCtD
Gadoversetamide—Diarrhoea—Etoposide—germ cell cancer	0.00132	0.00132	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Methotrexate—germ cell cancer	0.00131	0.00131	CcSEcCtD
Gadoversetamide—Malaise—Methotrexate—germ cell cancer	0.00127	0.00127	CcSEcCtD
Gadoversetamide—Dizziness—Etoposide—germ cell cancer	0.00127	0.00127	CcSEcCtD
Gadoversetamide—Vertigo—Methotrexate—germ cell cancer	0.00127	0.00127	CcSEcCtD
Gadoversetamide—Nausea—Cisplatin—germ cell cancer	0.00125	0.00125	CcSEcCtD
Gadoversetamide—Cough—Methotrexate—germ cell cancer	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Convulsion—Methotrexate—germ cell cancer	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Vomiting—Etoposide—germ cell cancer	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Rash—Etoposide—germ cell cancer	0.00121	0.00121	CcSEcCtD
Gadoversetamide—Dermatitis—Etoposide—germ cell cancer	0.00121	0.00121	CcSEcCtD
Gadoversetamide—Headache—Etoposide—germ cell cancer	0.00121	0.00121	CcSEcCtD
Gadoversetamide—Myalgia—Methotrexate—germ cell cancer	0.0012	0.0012	CcSEcCtD
Gadoversetamide—Arthralgia—Methotrexate—germ cell cancer	0.0012	0.0012	CcSEcCtD
Gadoversetamide—Chest pain—Methotrexate—germ cell cancer	0.0012	0.0012	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.0012	0.0012	CcSEcCtD
Gadoversetamide—Discomfort—Methotrexate—germ cell cancer	0.00119	0.00119	CcSEcCtD
Gadoversetamide—Confusional state—Methotrexate—germ cell cancer	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Methotrexate—germ cell cancer	0.00115	0.00115	CcSEcCtD
Gadoversetamide—Nausea—Etoposide—germ cell cancer	0.00114	0.00114	CcSEcCtD
Gadoversetamide—Nervous system disorder—Methotrexate—germ cell cancer	0.00113	0.00113	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Methotrexate—germ cell cancer	0.00113	0.00113	CcSEcCtD
Gadoversetamide—Skin disorder—Methotrexate—germ cell cancer	0.00112	0.00112	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Methotrexate—germ cell cancer	0.00112	0.00112	CcSEcCtD
Gadoversetamide—Anorexia—Methotrexate—germ cell cancer	0.0011	0.0011	CcSEcCtD
Gadoversetamide—Hypotension—Methotrexate—germ cell cancer	0.00108	0.00108	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.00105	0.00105	CcSEcCtD
Gadoversetamide—Insomnia—Methotrexate—germ cell cancer	0.00104	0.00104	CcSEcCtD
Gadoversetamide—Paraesthesia—Methotrexate—germ cell cancer	0.00104	0.00104	CcSEcCtD
Gadoversetamide—Dyspnoea—Methotrexate—germ cell cancer	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Somnolence—Methotrexate—germ cell cancer	0.00103	0.00103	CcSEcCtD
Gadoversetamide—Dyspepsia—Methotrexate—germ cell cancer	0.00102	0.00102	CcSEcCtD
Gadoversetamide—Decreased appetite—Methotrexate—germ cell cancer	0.001	0.001	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000996	0.000996	CcSEcCtD
Gadoversetamide—Fatigue—Methotrexate—germ cell cancer	0.000995	0.000995	CcSEcCtD
Gadoversetamide—Pain—Methotrexate—germ cell cancer	0.000987	0.000987	CcSEcCtD
Gadoversetamide—Feeling abnormal—Methotrexate—germ cell cancer	0.000951	0.000951	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000943	0.000943	CcSEcCtD
Gadoversetamide—Urticaria—Methotrexate—germ cell cancer	0.000917	0.000917	CcSEcCtD
Gadoversetamide—Abdominal pain—Methotrexate—germ cell cancer	0.000912	0.000912	CcSEcCtD
Gadoversetamide—Body temperature increased—Methotrexate—germ cell cancer	0.000912	0.000912	CcSEcCtD
Gadoversetamide—Hypersensitivity—Methotrexate—germ cell cancer	0.00085	0.00085	CcSEcCtD
Gadoversetamide—Asthenia—Methotrexate—germ cell cancer	0.000828	0.000828	CcSEcCtD
Gadoversetamide—Pruritus—Methotrexate—germ cell cancer	0.000816	0.000816	CcSEcCtD
Gadoversetamide—Diarrhoea—Methotrexate—germ cell cancer	0.000789	0.000789	CcSEcCtD
Gadoversetamide—Dizziness—Methotrexate—germ cell cancer	0.000763	0.000763	CcSEcCtD
Gadoversetamide—Vomiting—Methotrexate—germ cell cancer	0.000734	0.000734	CcSEcCtD
Gadoversetamide—Rash—Methotrexate—germ cell cancer	0.000727	0.000727	CcSEcCtD
Gadoversetamide—Dermatitis—Methotrexate—germ cell cancer	0.000727	0.000727	CcSEcCtD
Gadoversetamide—Headache—Methotrexate—germ cell cancer	0.000723	0.000723	CcSEcCtD
Gadoversetamide—Nausea—Methotrexate—germ cell cancer	0.000685	0.000685	CcSEcCtD
